A Bayesian estimate of the early COVID-19 infection fatality ratio in Brazil based on a random seroprevalence survey무작위 혈청 유병률 조사를 기반으로 한 브라질의 초기 COVID-19 감염 사망률에 대한 베이지안 추정Article Published on 2021-10-012022-09-11 Journal: International Journal of Infectious Diseases [Category] SARS, 치료기술, [키워드] 95% CI antibody average baseline value Bayesian Brazil country COVID-19 COVID-19 infection dataset datasets estimate estimates fatality health system IFR IgG antibody include Infection medication medications Prevalence random SARS-CoV-2 seroprevalence survey significantly subsequent Treatment protocol treatment protocols [DOI] 10.1016/j.ijid.2021.08.016 PMC 바로가기 [Article Type] Article
The serum amino acid profile in COVID-19COVID-19의 혈청 아미노산 프로필Clinical Trial Published on 2021-10-012022-09-11 Journal: Amino acids [Category] MERS, SARS, 바이오마커, 비임상, 임상, 치료기술, [키워드] addition Affect Amino acid amino acid metabolism amino acids BCAA BCAAs Biomarker branched-chain amino acid branched-chain amino acids breath can be used caused changed conducted control group coronavirus coronavirus disease correlation Course COVID patient Covid patients COVID-19 COVID-19 patient COVID-19 patients Determining develop Diagnosis Diseases examined group healthy Impact Infection information l-2-aminobutyric acid. L-phenylalanine Laboratory metabolism Mild moderate pandemic patient groups patients with asymptomatic Phenylalanine profile Prognosis prognostic SARS-CoV-2 SARS-COV-2 infection serum severity significant difference significant differences statistical analyses statistical analysis subject Taurine the disease Treatment treatment protocols [DOI] 10.1007/s00726-021-03081-w PMC 바로가기 [Article Type] Clinical Trial
Clinical Outcomes and Independent Risk Factors for 90-Day Mortality in Critically Ill Patients with Respiratory Failure Infected with SARS-CoV-2: A Multicenter Study in Turkish Intensive Care UnitsObservational Study Published on 2021-09-012022-10-05 Journal: Balkan medical journal [Category] 임상, [키워드] 24 hour age Cardiac arrhythmia clinical Clinical characteristics Cohort COVID-19 Critically ill patient demographics determine Factor failure Hospitalized ICU ICUs Ill IMV independent risk factor intensive care unit Invasive mechanical ventilation Laboratory laboratory-confirmed Lactate mechanical ventilation median age men Mortality mortality rate multicenter study outcome PaO2/FiO2 ratio Patient positive respiratory Respiratory failure risk factor severe hypoxemia survival therapy Treatment treatment protocols Turkey variables were recorded with COVID-19 [DOI] 10.5152/balkanmedj.2021.21188 PMC 바로가기 [Article Type] Observational Study
Customized treatment protocols for patients with closed fracture in hospitals at varying coronavirus disease 2019 (COVID-19) risk다양한 코로나 바이러스 질병 2019 (Covid-19) 위험에서 병원에서 닫힌 골절 환자를위한 맞춤형 치료 프로토콜Research Published on 2021-08-302022-09-10 Journal: BMC Musculoskeletal Disorders [Category] 치료기술, [키워드] adjusted analyzed change changed changes in Closed fracture confirmed case confirmed cases coronavirus disease Coronavirus disease 2019 (COVID-19) COVID-19 COVID-19 epidemic Cross-infection cumulative Delayed surgery determine discharged Efficiency Epidemic Fracture hospital hospitals IMPROVE initial Medical resources Optimization strategy Patient per day Perceived risk protocol Randomly Reflection Region Result risk Risk level of the epidemic selected study period sync Treatment Treatment protocol treatment protocols with COVID-19 Wuhan [DOI] 10.1186/s12891-021-04614-w PMC 바로가기 [Article Type] Research
Customized treatment protocols for patients with closed fracture in hospitals at varying coronavirus disease 2019 (COVID-19) riskResearch Published on 2021-08-302022-10-27 Journal: BMC Musculoskeletal Disorders [Category] COVID-19, [키워드] adjusted analyzed change changed changes in Closed fracture confirmed case coronavirus disease Coronavirus disease 2019 (COVID-19) COVID-19 COVID-19 epidemic Cross-infection cumulative Delayed surgery determine discharged Efficiency Epidemic hospital hospitals IMPROVE initial Medical resources Optimization strategy Patient per day Perceived risk protocol Randomly Region Result risk Risk level of the epidemic selected study period Treatment Treatment protocol treatment protocols with COVID-19 Wuhan [DOI] 10.1186/s12891-021-04614-w PMC 바로가기 [Article Type] Research
Customized treatment protocols for patients with closed fracture in hospitals at varying coronavirus disease 2019 (COVID-19) riskResearch Published on 2021-08-302022-10-27 Journal: BMC Musculoskeletal Disorders [Category] Coronavirus, COVID-19, MERS, SARS, [키워드] adjusted analyzed change changed changes in Closed fracture confirmed case coronavirus disease Coronavirus disease 2019 (COVID-19) COVID-19 COVID-19 epidemic Cross-infection cumulative Delayed surgery determine discharged Efficiency Epidemic hospital hospitals IMPROVE initial Medical resources Optimization strategy Patient per day Perceived risk protocol Randomly Region Result risk Risk level of the epidemic selected study period Treatment Treatment protocol treatment protocols with COVID-19 Wuhan [DOI] 10.1186/s12891-021-04614-w PMC 바로가기 [Article Type] Research
Management of the Oral Health of Children During the COVID-19 Pandemic in PolandPublic Health Published on 2021-07-292022-10-31 Journal: Frontiers in Public Health [Category] COVID-19, MERS, SARS, [키워드] Analysis approach children clinics COVID-19 COVID-19 pandemic decrease dentistry effective Frequency Future Health health emergency highest implication infection control lesion lesions lockdown lockdown restriction management managing mucosal New no difference non-specific oral oral health pandemic Patient pediatric performed Poland problems Prophylactic protocol protocols Pulp reached Regional shown Spread statistical difference surgical the disease therapy Treatment treatment protocols [DOI] 10.3389/fpubh.2021.635081 PMC 바로가기 [Article Type] Public Health
Evaluation of the efficacy and safety of recombinant erythropoietin on the improvement of hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial입원한 COVID-19 환자의 개선에 대한 재조합 에리트로포이에틴의 효능 및 안전성 평가: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약Letter Published on 2021-07-062022-09-10 Journal: Trials [Category] SARS, 임상, [키워드] 1:1 48 hours Adverse reaction Adverse reactions age approved Arm Bandar Abbas Blinding block randomization blood pressure Care checked chronic lung disease clinical clinical symptom clinical trial clinical trials Committee company comparator Patients composite endpoint control group Controlled clinical trial controls Coronary heart disease COVID-19 COVID-19 patient COVID-19 patients CRP Deep vein Deep vein thrombosis diabetes Diabetes Mellitus Diastolic blood pressure dissemination distilled water Efficacy and safety element End-stage renal disease endogenous enoxaparin erythropoietin ethics committee evaluate evaluate the effect excluded exclusion criteria expected Haemoglobin Health Health care heart disease hospitalised hospitalised COVID-19 patients Hypoxemia immune system infiltration injection intervals Intervention intervention group investigator Iran Laboratory test Laboratory tests LDH Liver disease Local Lung disease lung field lung infiltration lymphocyte Lymphocyte count lymphopenia Medical Science Medical Sciences medication minute number objective oral contraceptive outcome oxygen oxygen partial pressure oxygen saturation parallel-group partial pressure participant Patient PCR performed pharmaceutical Pharmaceutical Company Phase 2 Placebo positive Prevent principal investigator protocol randomised randomised controlled trial Randomized Randomly receive recombinant erythropoietin recruitment Registered registry renal disease reported respiratory respiratory rate Sample size saturation severe COVID-19 symptom severe COVID-19 symptoms Side effect Side effects Standard Standard of care status sterile water Study protocol subcutaneous injection subject supplementary material Systolic blood pressure tachypnea technology the ethics committee thrombosis title Treatment protocol treatment protocols Trial registration university vital signs water water for injection weakened immune system website [DOI] 10.1186/s13063-021-05363-w PMC 바로가기 [Article Type] Letter
COVID-19 neutralizing antibody-based therapies in humoral immune deficiencies: A narrative review체액성 면역 결핍증에서 코로나19 중화 항체 기반 요법: 내러티브 검토Review Published on 2021-06-012022-09-12 Journal: Transfusion and apheresis science : official journ [Category] MERS, SARS, 신약개발, 진단, [키워드] acute respiratory syndrome agammaglobulinemia Alymphocytosis anti-viral agents antibody-based therapy benefit cancers category caused Cell clinician congenital convalescent plasma coronavirus coronavirus disease COVID-19 COVID-19 patient deficiencies develop effective effort Evidence first positive Health hematologic humoral Hypogammaglobulinemia immune Immune deficiencies Immunotherapy Neutralizing Neutralizing antibodies organ outbreak Passive Patient patients recipient recovered patient Research SARS-CoV-2 severe COVID-19 patients therapy transplantation transplants treatment protocols [DOI] 10.1016/j.transci.2021.103071 PMC 바로가기 [Article Type] Review
Impact of daily high dose oral vitamin D therapy on the inflammatory markers in patients with COVID 19 disease매일 고용량 경구 비타민 D 요법이 코로나19 환자의 염증 표지자에 미치는 영향Randomized Controlled Trial Published on 2021-05-202022-08-13 Journal: Scientific Reports [Category] 바이오마커, 임상, 치료법, [키워드] added addition adjunctive Pulse D therapy analysed Biochemistry BMI COVID 19 COVID-19 COVID-19 patient CRP difference disease Diseases dysregulation evaluated ferritin group groups High dose Hypovitaminosis D IL6 immune dysregulation immunomodulator Impact Inflammatory marker inflammatory markers LDH marker Microbiology N/L ratio outcomes Pathogenesis Patient Pulse D therapy randomised reduced reducing reduction Seven Side effects significantly standard treatment standard treatment alone statistical significance subject Therapeutic improvement therapy Treatment protocol treatment protocols two group two groups variable Vitamin D vitamin D level with COVID-19 [DOI] 10.1038/s41598-021-90189-4 PMC 바로가기 [Article Type] Randomized Controlled Trial